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1. Introduction 
The two main effects of guanyl nucleotides on 
receptor-adenylate cyclase system are: 
(i) To permit stimulation of the enzyme by the hor- 
mone [ 11; and 
(ii) To modulate the affinity of the receptor for the 
agonist [2]. 
It has been shown that [3H]antagonist/agonist com- 
petition curves are shallow with ‘pseudo’ Hill slope 
of <l [3,4]. In the adrenergic sensitive adenylate 
cyclase of froperythrocytes [.5,6] these curves can be 
fitted with a model assuming that the fl-adrenergic 
receptors exist in two discrete and interconvertible 
states with a high and low affinity for the agonist, 
respectively. In the presence of GTP, the competition 
curves are steeper with ‘pseudo’ Hill slope -1 [5,6] 
indicating that all the receptors are under the low 
affinity state. Although a great number of studies has 
been done on these different states of the receptor 
using binding experiments, no attempt has been made 
to find experimental conditions in which it would be 
possible to compare both the characteristics of the 
two states of the receptor and those of the agonist- 
adenylate cyclase activation in the same preparation 
and under the same experimental conditions. We 
found such a study was possible in a crude membrane 
preparation of a muscle cell line, B&HI [7]. 
2. Materials and methods 
B&HI muscle cell line was a gift from Dr J. 
Patrick. They were grown as in [8]. For preparation 
of particulate fractions, cells were washed twice with 
0.150 M NaCl and scraped off with a rubber probe in 
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5 ml 0.15 M NaCl/dish. They were centrifuged for 
3 min at 400 X g and the pellet was homogenized 
at 0°C in 5 mM Tris-HCl (PH 7.6), 1 mM MgClz and 
0.4 mM EDTA (-5 X lo6 cells/ml) with a Teflon- 
glass homogenizer. The homogenates was diluted at 
-1.5 X lo6 cells/ml with the homogenization buffer 
filtered through a silk screen (150 pm pore diam.) 
and centrifuged for 5 min at 500 X g. The supernatant 
was then centrifuged for 15 min at 12 000 X g at 4°C. 
The pellet was resuspended in 50 mM Tris-HCl 
(pH 7.6), 25 mM MgClz and 10 mM EDTA at -4.5 
mg protein/ml. This particulate fraction was kept at 
0°C and used for experiments within 2 h. For (-)[3H]- 
dihydroalprenolol binding ( C3H] DHA) the particulate 
fractions (45Opg/ml in the final assay) were incubated 
for 10 min at 30°C in 200 ~1 of a medium containing 
(50 mM Tris-HCl (pH 7.6), 2.5 mM MgCl*, 1 mM 
EDTA, 0.1 mM ATP, 0.4 IU/ml of adenosine deami- 
nase, 10 mM phosphocreatine, 0.2 mg creatine kinase/ 
ml, 0.1 mM papaverine and l-2 nM [3H]DHA). Incu- 
bations were terminated by addition of 1 ml ice-cold 
medium (50 mM Tris-HCl (pH 7.6) and 10 mM 
MgCl*) followed by rapid filtration through Whatman 
GF/B glass fiber filters. The latter were washed with 
15 ml of the same medium. Specific binding was 
defined as the binding which is inhibited by 30 I.~M 
isoproterenol(60% of total binding). Adenylate 
cyclase assays were done in the same medium except 
that trace amounts of c[~H] AMP (0.001 &i) and 
[(u-32P]ATP (1.5 &i) were added. The reaction was 
stopped and c [“‘PI AMP purified as in [9]. Computer 
analysis was done by a non-linear least square curve 
fitting procedure as in [ 10). 
Using the extra sum of square principle as applied 
in [6], the goodness of the fit was evaluated in bind- 
ing studies assuming that the receptor has either 1 or 
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2 affinity states and in adenylate cyclase studies 
assuming that the adenylate cyclase activation has 
either 1 or 2 components. 
3. Results 
3.1. Binding experiments 
They were done in an adenylate cyclase medium. 
Scatchard analysis indicated that [3H] DHAinteracted 
with one category of binding sites (Kd 1.2 nM, 
B max 50 fmol/mg protein). C3H] DHA binding prop- 
erties have been described [8]. As in other systems 
in the absence of added GTP, the [3H]antagonist/ 
agonist curves were shallow (fig.1). Computer analysis 
indicated that the best fit was obtained with a model 
that involved [3H]DHA labelling 2 populations of 
sites with the same Kd for the labelled antagonist 
and different affinities for the agonist (F= 12,~ < 0.01 
when compared to a 1 site model). For isoproterenol 
45% of the receptors have high affinity (RH) with 
dissociation constant (Kd,H) of 10.7 nM and 55% 
have a low affinity (Kd,L) of 256 nM (mean values 
in table 1). Similar results were obtained with salbu- 
tamol, epinephrine, norepinephrine. The percentage 
of R, was not statistically different for these differ- 
ent agonists (table 1). In the presence of GTP (10” M) 
the competition curve for isoproterenol shifted to 
the right and steepened. Computer modeling indicated 
that only one state was present having a low affinity 
component (Kd L = 220 nM) (fig.1). This affinity 
was nearly idenkcal to that of the low affinity com- 
ponent (Kd,L) determined in the absence of GTP 
(fig.1). Mean values confirmed that K, L were not 
statistically different when determined’in the absence 
or the presence of GTP for both isoproterenol and 
salbutamol (table 1). 
3.2. Adenylate cyclase experiments 
In the absence of agonist, the basal adenylate 
cyclase was highly stimulated by GTP (1 S-20-fold). 
Stimulation was apparent at 1 0e7 M and maximal 
at 5 X 1 O-’ M. When no GTP was added, isoproterenol 
enhanced basal adenylate cyclase activity (2.4 k O.l- 
(4 without GTP 
(d I@ M GTP 
r KD H = 10.7 nM (45 %) 
0 I KD L = 256 nM (55.1.) 
KD’H = - (0) 
0 
‘D L = 220 nM (lOO*/.) 
ISOPROTERENOL (Ml 
Fig.1. Computerized fitting data obtained from the displacement of [3H]DHA by isoproterenol in the presence and absence of 
GTP. [ 3H]DHA was 1.7 nM. The specific binding was 32 fmol/mg protein in the absence (0) and the presence (o) of GTP ( 10e4 M). 
Experimental points are the means of triplicate determination. Dashed lines represent the computer-generated curves fitting the 
observed data. 
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Table 1 
Computer-model parameters of agonist interaction with [3H]DHA binding sites 
Agonist 
(-) Isoproterenol (4) 
(-) Isoproterenol 
%RH Kd,H (nM) Kd L (nM) 
515 I 19.2 r 5.9 205 * 45a,c 
+ 1O-4 M GTP (5) 0 - 273 f 84dn.s. 
(t) Salbutamol (3) 48t 9 240 f 75 2290 + 370’~~ 
(t) Salbutamol 
+ 1O-4 M GTP (3) 0 _ 2560 r 1lOOdn.s. 
(-) Epinephrine (3) 42r 11 11 + 3 427 f 20ayc 
(-) Norepinephrine (3) 42* 5 523 +98 13 300 i 4000bJ 
% RH is the percentage of total receptors in the high affinity state. Kd H and 
Kd L are the respective dissociation constants for the high and low affinity states 
of {he receptor. The number of experiments is given in parentheses. The results 
are expressed as means f SEM. Statistical analysis was done using Student’s 
t-test: a p < 0.01; b p < 0.05 ; n.s. not significant; c comparison between Kd L 
andKd.H; d comparison betWeenKd_L determined in the absence and the prelence 
of GTP’ 
fold, n = 6). This stimulation is probably due to a 
low GTP contamination of our preparation. In the 
presence of increasing concentration of GTP the 
accumulation of AMP due to the agonist increased. 
This GTP effect was already significant at 3 X lo-’ M 
and maximal at 3 X 10e6 M. In the absence of added 
GTP, the dose-response for adenylate cyclase activa- 
tion by isoproterenol was shallowed (fig.2A). Stimu- 
lation was clearly significant at 1 OW9 M and maximal 
at 10e6 M. The Hofstee plot of this dose-activation 
curve was curvilinear (fig2B) indicating that it cannot 
be described by simple mass-action kinetics. Computer 
modeling indicated that the best fit was obtained 
assuming that the dose-activation curve was the sum 
of two Michaelis-Menten components (F = 29, 
p < 0.001 when compared with a one component 
model). The high affinity one had a K, (concentra- 
tion giving half-maximal activation of 2.9 nM) and 
was responsible for 59% of the total adenylate cyclase 
activation. The low affinity one had a K, of 140 nM 
and was responsible for 41% of the total activation 
(mean values in table 2). Similar results were obtained 
for several agonists and the proportions of high and 
low affinity components were not statistically differ- 
ent except for norepinephrine. To make sure that 
proportions of high and low affinity components 
were determined at steady state, the dose-activation 
May 1981 
curves were examined either from O-5 min or from 
5-10 min. Identical results were obtained (not shown). 
In the presence of GTP (IO4 M) the dose-activation 
curve for agonists shifted to the right (fig.2A). Only 
one component was detected by computer modeling 
and by Hofstee plot (fig.2C). Its K, (Ka,CL) was very 
close to that of the low affinity component determined 
in the absence of added GTP (fig.2A). Statistical 
analysis on isoproterenol and salbutamol dose-activa- 
tion curves done in the presence or the absence of 
GTP confirmed this result. 
4. Discussion 
Binding experiments showing 2 states of the 
P-adrenergic receptor were conducted in simple Tris 
buffer conditions[5,6]. In our system, these 2 states 
were detectable by binding experiments conducted 
in a medium allowing measurement of adenylate 
cyclase activity and its stimulation by agonists. The 
% of the total receptor population in the high affinity 
state was very similar, irrespective of the agonist 
tested (table 1). In [S] there was a correlation between 
the intrinsic activity of the agonist and the propor- 
tion of the high affinity component. However in our 
system the intrinsic activity of the agonists only 
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Fig.2. Effect of increasing concentration of isoproterenol on the adenylate cyclase activity in the presence and absence of GTP. 
(A) Increase in CAMP production by isoproterenol in the absence (0) and presence (o) of lo-“ M GTP. Experimental points are 
the means of a triplicate determination. Dashed lines represent the computer-generated curves fitting the observed data. Here, the 
basal adenylate cyclase activities were 24 pmol . 10 min-’ . mg protein-’ in the absence of GTP and 496 pmol . 10 min-’ . mg 
protein-’ in the presence of 10e4 M GTP. (B,C) Hofstee plots for the doseeresponse curves obtained for isoproterenol in the 
absence of GTP (B) and in the presence of lo-“ M GTP (C). V is the adenylate cyclase activity in the presence of isoproterenol, 
minus basal activity. S = isoproterenol concentration (in mol/l). 
varied from 80-l 0% (table 2) and therefore such a 
correlation is difficult to detect. In the presence of 
GTP the number of /3-adrenergic receptors did not 
change and all the receptors are under a low affinity 
state. The fact that the affinity of this state did not 
statistically differ from the affinity of the low affinity 
state detected in the absence of added GTP suggests 
that in the presence of GTP the high affinity state has 
been converted to a low affinity state. 
Similarly, the dose-response curves for adenylate 
cyclase activation by agonists were biphasic in the 
absence of added GTP and could be resolved in two 
Michaelis-Menten components with high and low 
affinity for agonists. The % of high affinity compon- 
nent did not statistically differ (see table 2) from the 
% of high affinity state detected in binding experi- 
ments except for norepinephrine (tables 1,2). In the 
presence of GTP only 1 component was detected 
having a K, which did not statistically differ from the 
K, of the low affinity component detected without 
added GTP (fig.2, table 2). The shift in K, to the 
lower values seen here in the presence of GTP has 
been also been described in [3] in Sa9 murine lym- 
phoma cell membranes. The K, of the high affinity 
components (K,CH) was 2.8 f 0.2 nM (n = 6). To 
our knowledge such a high affinity component has 
never been reported for an isoproterenol-sensitive 
adenylate cyclase in an in vitro system. This is probably 
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Table 2 
Computer-modeled parameters of agonist activation of adenylate cyclase 
Agonist Intrinsic 
activity 
%CH K,,CH (nM) K,,CL (nM) 
(-) Isoproterenol(6) 1 39 + @ n.s. 2.8 f 0.8 72 r 23a*d 
(-) Isoproterenol 
+ 1O-4 M GTP (4) - 0 _ 68 f lib n.s. 
(t) Salbutamol(4) 0.80 * 0.04 47.5 k 13”n.s. 56 + 12 500 f 90a,d 
(+) Salbutamol 
+ 1O-4 M GTP - 0 _ 571 + 55b n.s. 
(-) Epinephrine (3) 1.05 f 0.02 39 f 6’n.s. 20 f 2 358 * 119a,e 
(-) Epinephrine 
+ 1O-4 M GTP (1) - 0 - 360 
(-) Norepinephrine (3) 0.93 f 0.01 75 f 6ce 565 * 83 30 500 k 3400a9d 
Intrinsic activity was defined as the ratio of the maximal activation of adenylate cyclase achieved by 
the agonist tested with no added GTP to the maximal activation achieved by (-) isoproterenol. % CH 
is the percentage of total activity in the high affinity component. K, CH and Ka,cL are $e respective 
K, for the high and low affinity components. a Comparison between’Ka.CH and K,,CL; comparison 
between Ka,CL determined in the absence and the presence of GTP; c comparison between % CH 
(table 2) and % RH (table 1) for each agonist; d p < 0.01; e p < 0.05 ; n.s. not significant 
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because most of the studies on fl-adrenergic sensitive 
adenylate cyclase have been done with high GTP con- 
centrations. 
Our data clearly demonstrated that two states of 
Padrenergic receptors could be detected both by 
binding experiments and by analysis of the adenylate 
cyclase dose-activation curves in the absence of 
added GTP. The main question arising from our 
results is whether or not the 2 components of adenyl- 
ate cyclase are directly related to the 2 states of the 
/I-adrenergic receptors. We have no direct experimental 
proof allowing a positive answer. However, the dis- 
appearance of both the high affinity component of 
the adenylate cyclase and the high affinity state of 
binding in the presence of a high concentration of 
GTP constitutes a good indication in favor of a direct 
relationship between them. There is ‘still a debate to 
whether 1 or 2 nucleotide-binding proteins are 
involved in the 2 main effects of guanyl nucleotides, 
i.e., hormonal stimulation and the decrease in agonist 
affinity for the receptor [ 11 ,121. A recent model [6] 
implies only 1 nucleotide binding protein. These 
authors suggested that the high affinity state of the 
receptor is a ternary complex RI-IN (N, nucleotide 
binding protein) in which N is occupied by GDP 
(RHNGDP). In the presence of GTP and hormone, this 
complex rapidly dissociates and the N unit loaded 
with GTP activates the catalytic unit of the adenylate 
cyclase. The dissociation of N also leads to the forma- 
tion of an RH complex of low affinity. 
If we take this model into consideration our results 
could only be explained if one admits that the high 
affinity state (RHNGDP) can be coupled with the 
catalytic unit. Indeed in &a [ 121, NS 20 neuroblast- 
oma cell and corpora latea membranes, GDP was able 
to promote coupling under experimental conditions 
in which the proportion of GDP converted to GTP 
was negligible. 
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